Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment
Jacqueline K Flynn, Gregory J Dore, Margaret Hellard, Barbara Yeung, William D Rawlinson, Peter A White, John M Kaldor, Andrew R Lloyd, Rosemary A Ffrench
Journal of Gastroenterology and Hepatology | WILEY | Published : 2013
Awarded by National Institutes of Health
Awarded by NATIONAL INSTITUTE ON DRUG ABUSE
This paper was funded by the National Institutes of Health grant R01 DA15999 and the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. Roche Pharmaceuticals supplied financial support for pegylated IFN-alfa-2a/ribavirin. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.